Bengaluru company launches low-cost treatment for blood cancer

Immuneel Therapeutics, co-founded by Kiran Mazumdar-Shaw, has introduced Qartemi, India's second CAR-T cell therapy, to treat B-cell Non-Hodgkin Lymphoma. This therapy is priced at a fraction of similar treatments in the West and offers a new option for aggressive blood cancers.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/aN72ZvG
via IFTTT